Search results
Results from the WOW.Com Content Network
The company's origins go back to a Massachusetts real estate investment trust organized in 1969 as DMG, Inc. In 1978, DMG, Inc. was reorganized as a Florida corporation and changed its name to Diversified Mortgage Investors, Inc. DMG had been invested in retirement home developments when it was taken over by the Rales brothers, and in 1984, the company adopted the name Danaher and ...
The transaction closed in August 2015, with Danaher paying $127.20 per share or about $13.8 billion. The acquisition was completed on August 31, 2015. [21] In September 2022, it was announced that Pall Life Sciences will be merging with Cytiva to create a new Biotechnology Group within Danaher. [22]
The initial public offering was June 21, 2000 at US$6 per share. Cepheid stock was listed on the Nasdaq under the ticker symbol CPHD until it was acquired by Danaher in 2016. [35] [third-party source needed] The company's first CEO was Tom Gutshall, who held the position from 1996 to 2002. [36] In April 2002, John L. Bishop was appointed CEO. [2]
In the latest trading session, Danaher (DHR) closed at $274.23, marking a -0.11% move from the previous day.
Danaher (DHR) outperforms its industry and the S&P 500 year to date on solid financial performances, buyout gains, solid product demand, shareholder-friendly policies and other factors.
Danaher's (NYSE:DHR) stock up by 5.6% over the past three months. As most would know, long-term fundamentals have a... Danaher Corporation's (NYSE:DHR) Stock Has Shown A Decent Performance: Have ...
Danaher's (NYSE:DHR) stock up by 2.3% over the past month. Since the market usually pay for a company’s long-term...
On Tuesday, Danaher Corp (NYSE:DHR) reported third-quarter sales of $5.79 billion, up 3% year-over-year, beating the consensus of $5.59 billion. Guidance: Danaher reaffirms that in fiscal year ...